Jump to content

Vamicamide

From Wikipedia, the free encyclopedia
Vamicamide
Clinical data
Other namesUrocut
Identifiers
  • (2R,4R)-4-(dimethylamino)-2-phenyl-2-pyridin-2-ylpentanamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H23N3O
Molar mass297.402 g·mol−1
3D model (JSmol)
  • C[C@H](C[C@@](C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)N(C)C
  • InChI=1S/C18H23N3O/c1-14(21(2)3)13-18(17(19)22,15-9-5-4-6-10-15)16-11-7-8-12-20-16/h4-12,14H,13H2,1-3H3,(H2,19,22)/t14-,18-/m1/s1
  • Key:BWNLUIXQIHPUGO-RDTXWAMCSA-N

Vamicamide is an antimuscarinic drug.[1]

Vamicamide should be useful for the treatment of urinary frequency.[2]

See also: Aminopentamide (Dimevamide).

References

[edit]
  1. ^ Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45(12):1274-84. PMID: 8595084.
  2. ^ Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol. 1995 Dec;154(6):2174-8. PMID: 7500484.